Study Description
This is a single arm, multicenter, observational study to evaluate the safety and
efficacy of Entresto Tablets during the first 52 weeks of treatment in Japanese patients
with hypertension. This study is a special drug use surveillance to collect information on the safety
specifications under the actual clinical practice of Entresto Tablets in patients with
hypertension in Japan to confirm the occurrence and timing of onset of events related to
the safety specifications and investigate their risk factors.
Interventions
Entresto
Eligibility Criteria
Inclusion Criteria:
1. Patients who have given written consent to participate in this study before the
start of treatment with Entresto
2. Patients who used Entresto for the first time for the indication of hypertension
Exclusion Criteria:
1. Patients who have received a formulation containing the same ingredient as Entresto
(including investigational product or post-marketing clinical study drug)
2. The following patients for whom administration of Entresto is contraindicated in the
package insert:
- Patients with a history of hypersensitivity to any of the ingredients of
Entresto
- Patients who are receiving angiotensin-converting enzyme inhibitors (alacepril,
imidapril hydrochloride, enalapril maleate, captopril, quinapril hydrochloride,
cilazapril hydrate, temocapril hydrochloride, delapril hydrochloride,
trandolapril, benazepril hydrochloride, perindopril erbumine, and lisinopril
hydrate) or who discontinued these drugs within 36 hours.
- Patients with a history of angioedema (angioedema due to angiotensin II
receptor antagonists or angiotensin converting enzyme inhibitors, hereditary
angioedema, acquired angioedema, idiopathic angioedema, etc.)
- Patients with diabetes mellitus who are receiving aliskiren fumarate
- Patients with severe hepatic impairment (Child-Pugh class C)
- Pregnant or possibly pregnant women
3. Patients with a history or complication of cardiac failure
4. Patients who have been hospitalized at the start of treatment with Entresto
Study Location
Novartis Investigative Site
Recruiting
Kobe,Hyogo,651-1302,Japan
Novartis Investigative Site
Recruiting
Takaoka,Toyama,939-1104,Japan
Novartis Investigative Site
Recruiting
Nagasaki,851-2211,Japan
Novartis Investigative Site
Recruiting
Yokohama,Kanagawa,232-0052,Japan
Novartis Investigative Site
Recruiting
Fukuoka,810-0801,Japan
Novartis Investigative Site
Recruiting
Sapporo,Hokkaido,060-0031,Japan
Novartis Investigative Site
Recruiting
Kasuya-gun,Fukuoka,811-2202,Japan
Novartis Investigative Site
Recruiting
Minoo,Osaka,562-0046,Japan
Novartis Investigative Site
Recruiting
Toyonaka,Osaka,561-0881,Japan
Novartis Investigative Site
Recruiting
Anjo,Aichi,444-1154,Japan
Novartis Investigative Site
Recruiting
Osaka,534-0024,Japan
Novartis Investigative Site
Recruiting
Inzai,Chiba,270-1334,Japan
Novartis Investigative Site
Recruiting
Takatsuki,Osaka,569-1121,Japan
Novartis Investigative Site
Recruiting
Kumamoto,862-0924,Japan
Novartis Investigative Site
Recruiting
Nagoya,Aichi,461-0045,Japan
Novartis Investigative Site
Recruiting
Yokohama,Kanagawa,235-0045,Japan
Novartis Investigative Site
Recruiting
Gyoda,Saitama,361-0056,Japan
Novartis Investigative Site
Recruiting
Satte,Saitama,340-0115,Japan
Novartis Investigative Site
Recruiting
Kita-Katsuragi-gun,Nara,636-0002,Japan
Novartis Investigative Site
Recruiting
Ureshino,Saga,843-0302,Japan
Novartis Investigative Site
Recruiting
Atsugi,Kanagawa,243-0013,Japan
Novartis Investigative Site
Recruiting
Mitaka,Tokyo,181-0013,Japan
Novartis Investigative Site
Recruiting
Ota,Tokyo,146-8531,Japan
Novartis Investigative Site
Recruiting
Iruma,Saitama,358-0026,Japan
Novartis Investigative Site
Recruiting
Takehara,Hiroshima,725-0026,Japan
Novartis Investigative Site
Recruiting
Kurashiki,Okayama,710-1101,Japan
Novartis Investigative Site
Recruiting
Yokohama,Kanagawa,241-0821,Japan
Novartis Investigative Site
Recruiting
Hachioji-city,Tokyo,192-0918,Japan
Novartis Investigative Site
Recruiting
Nakagawa,Fukuoka,811-1244,Japan
Novartis Investigative Site
Recruiting
Setagaya-ku,Tokyo,157-0066,Japan
Novartis Investigative Site
Recruiting
Sayama,Saitama,350-1305,Japan
Novartis Investigative Site
Recruiting
Kitakyushu,Fukuoka,804-0081,Japan
Novartis Investigative Site
Recruiting
Yame,Fukuoka,834-0004,Japan
Novartis Investigative Site
Recruiting
Bunkyo-ku,Tokyo,113-0031,Japan
Novartis Investigative Site
Recruiting
Moriguchi,Osaka,570-0012,Japan
Novartis Investigative Site
Recruiting
Kagoshima,892-0862,Japan
Novartis Investigative Site
Recruiting
Saitama,330-0074,Japan
Novartis Investigative Site
Recruiting
Tokorozawa,Saitama,359-1106,Japan
Novartis Investigative Site
Recruiting
Kurashiki,Okayama,713-8121,Japan
Novartis Investigative Site
Recruiting
Yokosuka,Kanagawa,238-0007,Japan
Novartis Investigative Site
Recruiting
Hirakata,Osaka,573-0058,Japan
Novartis Investigative Site
Recruiting
Nakatsu,Oita,871-0152,Japan
Novartis Investigative Site
Recruiting
Kitakyushu,Fukuoka,805-0019,Japan
Novartis Investigative Site
Recruiting
Suita,Osaka,565-0862,Japan
Novartis Investigative Site
Recruiting
Yokohama,Kanagawa,225-0013,Japan
Novartis Investigative Site
Recruiting
Chikusei,Ibaraki,309-1195,Japan
Novartis Investigative Site
Recruiting
Moriguchi,Osaka,570-8507,Japan
Novartis Investigative Site
Recruiting
Kanazawa,Ishikawa,920-0007,Japan
Novartis Investigative Site
Recruiting
Saitama,338-0837,Japan
Novartis Investigative Site
Recruiting
Kurume city,Fukuoka,830-0011,Japan
Novartis Investigative Site
Recruiting
Toshima-ku,Tokyo,170-0004,Japan
Novartis Investigative Site
Recruiting
Aiko-gun,Kanagawa,243-0301,Japan
Novartis Investigative Site
Recruiting
Ichinomiya,Aichi,494-0001,Japan
Novartis Investigative Site
Recruiting
Niiza,Saitama,352-0023,Japan
Novartis Investigative Site
Recruiting
Kitamoto-city,Saitama,364-8501,Japan
Novartis Investigative Site
Recruiting
Suita,Osaka,565-0874,Japan
Novartis Investigative Site
Recruiting
Moriya-city,Ibaraki,302-0102,Japan
Novartis Investigative Site
Recruiting
Yokohama,Kanagawa,2260025,Japan
Novartis Investigative Site
Recruiting
Edogawa-ku,Tokyo,134-0081,Japan
Novartis Investigative Site
Recruiting
Kasai,Hyogo,679-0103,Japan
Novartis Investigative Site
Recruiting
Sakura,Chiba,285-8765,Japan
Novartis Investigative Site
Recruiting
Matsudo,Chiba,270-0034,Japan
Novartis Investigative Site
Recruiting
Toshima-ku,Tokyo,171-0014,Japan
Novartis Investigative Site
Recruiting
Akashi,Hyogo,673-0023,Japan
Novartis Investigative Site
Recruiting
Omuta,Fukuoka,837-0916,Japan
Novartis Investigative Site
Recruiting
Ikeda,Osaka,563-0047,Japan
Novartis Investigative Site
Recruiting
Kobe,Hyogo,650-0047,Japan
Novartis Investigative Site
Recruiting
Tachikawa,Tokyo,190-0023,Japan
Novartis Investigative Site
Recruiting
Nagasaki-shi,Nagasaki,852-8511,Japan
Novartis Investigative Site
Recruiting
Yokohama,Kanagawa,227-0046,Japan
Novartis Investigative Site
Recruiting
Fujimino,Saitama,356-0011,Japan
Novartis Investigative Site
Recruiting
Sapporo,Hokkaido,001-0017,Japan
Novartis Investigative Site
Recruiting
Kasuga,Fukuoka,816-0833,Japan
Novartis Investigative Site
Recruiting
Matsuyama,Ehime,790-0051,Japan
Novartis Investigative Site
Recruiting
Tosu,Saga,841-0061,Japan
Novartis Investigative Site
Recruiting
Amagasaki,Hyogo,660-0861,Japan
Novartis Investigative Site
Recruiting
Osaka,533-0013,Japan
Novartis Investigative Site
Recruiting
Iki-city,Nagasaki,811-5135,Japan
Worldwide Contacts
If the location of your choosing does not feature any contact detail, please reach out using the information below.